@xconomy.com 10 months ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com 1 year ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@engadget.com 1 year ago
AI could be the key to catching Type 1 diabetes much earlier
@xconomy.com 2 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com 2 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests